1-6 of 6
Gil Leibowitz
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Effect of Saxagliptin on Renal Outcomes in the SAVOR-TIMI 53 Trial

Ofri Mosenzon, Gil Leibowitz, Deepak L. Bhatt, Avivit Cahn, Boaz Hirshberg, Cheryl Wei, KyungAh Im, Aliza Rozenberg, Ilan Yanuv, Christina Stahre, Kausik K. Ray, Nayyar Iqbal, Eugene Braunwald, Benjamin M. Scirica, Itamar Raz
Journal: Diabetes Care
Diabetes Care 2017;40(1):69–76
https://doi.org/10.2337/dc16-0621
Published: 17 October 2016
View article titled, Effect of Saxagliptin on Renal Outcomes in the SAVOR-TIMI 53 Trial
Open the PDF for Effect of Saxagliptin on Renal Outcomes in the SAVOR-TIMI 53 Trial in another window
Includes: Supplementary data
Journal Articles

Anti-inflammatory Agents in the Treatment of Diabetes and Its Vascular Complications

Rena M. Pollack, Marc Y. Donath, Derek LeRoith, Gil Leibowitz
Journal: Diabetes Care
Diabetes Care 2016;39(Supplement_2):S244–S252
https://doi.org/10.2337/dcS15-3015
Published: 16 July 2016
View article titled, Anti-inflammatory Agents in the Treatment of Diabetes and Its Vascular Complications
Open the PDF for Anti-inflammatory Agents in the Treatment of Diabetes and Its Vascular Complications in another window
Journal Articles

Predisposing Factors for Any and Major Hypoglycemia With Saxagliptin Versus Placebo and Overall: Analysis From the SAVOR-TIMI 53 Trial

Avivit Cahn, Itamar Raz, Ofri Mosenzon, Gil Leibowitz, Ilan Yanuv, Aliza Rozenberg, Nayyar Iqbal, Boaz Hirshberg, Mikaela Sjostrand, Christina Stahre, KyungAh Im, Estella Kanevsky, Benjamin M. Scirica, Deepak L. Bhatt, Eugene Braunwald
Journal: Diabetes Care
Diabetes Care 2016;39(8):1329–1337
https://doi.org/10.2337/dc15-2763
Published: 23 May 2016
View article titled, Predisposing Factors for Any and Major Hypoglycemia With Saxagliptin Versus Placebo and Overall: Analysis From the SAVOR-TIMI 53 Trial
Open the PDF for Predisposing Factors for Any and Major Hypoglycemia With Saxagliptin Versus Placebo and Overall: Analysis From the SAVOR-TIMI 53 Trial in another window
Includes: Supplementary data
Journal Articles

Decreased Serum Concentrations of 25-Hydroxycholecalciferol Are Associated With Increased Risk of Progression to Impaired Fasting Glucose and Diabetes

Anat Tsur, MD, Becca S. Feldman, SCD, Ilan Feldhammer, MA, Moshe B. Hoshen, PHD, Gil Leibowitz, MD, Ran D. Balicer, MD
Journal: Diabetes Care
Diabetes Care 2013;36(5):1361–1367
https://doi.org/10.2337/dc12-1050
Published: 13 April 2013
View article titled, Decreased Serum Concentrations of 25-Hydroxycholecalciferol Are Associated With Increased Risk of Progression to Impaired Fasting Glucose and Diabetes
Open the PDF for Decreased Serum Concentrations of 25-Hydroxycholecalciferol Are Associated With Increased Risk of Progression to Impaired Fasting Glucose and Diabetes in another window
Journal Articles

Response to Mastrototaro and Gross

Muriel Metzger, MD, Gil Leibowitz, MD, Julio Wainstein, MD, Benjamin Glaser, MD, Itamar Raz, MD
Journal: Diabetes Care
Diabetes Care 2003;26(1):256–257
https://doi.org/10.2337/diacare.26.1.256-a
Published: 01 January 2003
View article titled, Response to Mastrototaro and Gross
Open the PDF for Response to Mastrototaro and Gross in another window
Journal Articles

Reproducibility of Glucose Measurements Using the Glucose Sensor

Muriel Metzger, MD, Gil Leibowitz, MD, Julio Wainstein, MD, Benjamin Glaser, MD, Itamar Raz, MD
Journal: Diabetes Care
Diabetes Care 2002;25(7):1185–1191
https://doi.org/10.2337/diacare.25.7.1185
Published: 01 July 2002
View article titled, Reproducibility of Glucose Measurements Using the Glucose Sensor
Open the PDF for Reproducibility of Glucose Measurements Using the Glucose Sensor in another window